This trial is looking at using 18F-DOPA PET/CT imaging in specific patient populations to see if it can help optimize images and identify gallbladder activity patterns.
4 Primary · 2 Secondary · Reporting Duration: Within 1 month of PET/CT scan
800 Total Participants · 1 Treatment Group
Primary Treatment: 18F-DOPA · No Placebo Group · Phase 3
Age Any Age · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: